Response to taxanes in triple negative breast cancer

被引:0
作者
Nilufer Bulut
Sadettin Kilickap
Ebru Sari
Kadri Altundag
机构
[1] Hacettepe University,Department of Medical Oncology, Institute of Oncology
来源
Cancer Chemotherapy and Pharmacology | 2008年 / 63卷
关键词
Breast Cancer; Paclitaxel; Doxorubicin; Taxanes; Triple Negative Breast Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:189 / 189
相关论文
共 50 条
[31]   Comparison of the efficacy of taxanes with carboplatin and anthracyclines with taxanes in neoadjuvant chemotherapy for stage II-III triple negative breast cancer: a retrospective analysis [J].
Wang, Huibo ;
Zhang, Nana ;
Sun, Qi ;
Zhao, Ziqi ;
Pang, Hui ;
Huang, Xiatian ;
Zhang, Ruifeng ;
Kang, Wenli ;
Shan, Ming .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (06)
[32]   Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells [J].
Espanol, Alejandro ;
Sanchez, Yamila ;
Salem, Agustina ;
Obregon, Jaqueline ;
Elena Sales, Maria .
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2022, 13 (06) :505-519
[33]   Predicting response and survival in chemotherapy-treated triple-negative breast cancer [J].
Prat, A. ;
Lluch, A. ;
Albanell, J. ;
Barry, W. T. ;
Fan, C. ;
Chacon, J. I. ;
Parker, J. S. ;
Calvo, L. ;
Plazaola, A. ;
Arcusa, A. ;
Segui-Palmer, M. A. ;
Burgues, O. ;
Ribelles, N. ;
Rodriguez-Lescure, A. ;
Guerrero, A. ;
Ruiz-Borrego, M. ;
Munarriz, B. ;
Lopez, J. A. ;
Adamo, B. ;
Cheang, M. C. U. ;
Li, Y. ;
Hu, Z. ;
Gulley, M. L. ;
Vidal, M. J. ;
Pitcher, B. N. ;
Liu, M. C. ;
Citron, M. L. ;
Ellis, M. J. ;
Mardis, E. ;
Vickery, T. ;
Hudis, C. A. ;
Winer, E. P. ;
Carey, L. A. ;
Caballero, R. ;
Carrasco, E. ;
Martin, M. ;
Perou, C. M. ;
Alba, E. .
BRITISH JOURNAL OF CANCER, 2014, 111 (08) :1532-1541
[34]   Exogenous Metabolic Modulators Improve Response to Carboplatin in Triple-Negative Breast Cancer [J].
Ho, Alyssa N. ;
Kiesel, Violet A. ;
Gates, Claire E. ;
Brosnan, Bennett H. ;
Connelly, Scott P. ;
Glenny, Elaine M. ;
Cozzo, Alyssa J. ;
Hursting, Stephen D. ;
Coleman, Michael Francis .
CELLS, 2024, 13 (10)
[35]   Triple-Negative Breast Cancer: Molecular Particularities Still a Challenge [J].
Varzaru, Vlad Bogdan ;
Vlad, Tania ;
Popescu, Roxana ;
Vlad, Cristian Sebastian ;
Moatar, Aurica Elisabeta ;
Cobec, Ionut Marcel .
DIAGNOSTICS, 2024, 14 (17)
[36]   Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancer [J].
Stover, Daniel G. ;
Winer, Eric P. .
BREAST, 2015, 24 :S132-S135
[37]   Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research [J].
Pont, Mariona ;
Marques, Marta ;
Sorolla, Maria Alba ;
Parisi, Eva ;
Urdanibia, Izaskun ;
Morales, Serafin ;
Salud, Antonieta ;
Sorolla, Anabel .
CANCERS, 2023, 15 (17)
[38]   Analysis of the differences of serum protein mass spectrometry in patients with triple negative breast cancer and non-triple negative breast cancer [J].
Liu, Ai-na ;
Sun, Ping ;
Liu, Jian-nan ;
Yu, Cai-yan ;
Qu, Hua-jun ;
Jiao, Ai-hong ;
Zhang, Liang-ming .
TUMOR BIOLOGY, 2014, 35 (10) :9751-9757
[39]   Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-up [J].
Zheng, Fangchao ;
Du, Feng ;
Wang, Wenmiao ;
Wang, Yongsheng ;
Li, Ming ;
Zhao, Jiuda ;
Wang, Xue ;
Yue, Jian ;
Wang, Jiayu ;
Yang, Zixuan ;
Cai, Ruigang ;
Ma, Fei ;
Fan, Ying ;
Li, Qing ;
Zhang, Pin ;
Xu, Binghe ;
Yuan, Peng .
BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (01) :97-105
[40]   Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction [J].
Coleman, Michael F. ;
O'Flanagan, Ciara H. ;
Pfeil, Alexander J. ;
Chen, Xuewen ;
Pearce, Jane B. ;
Sumner, Susan ;
Krupenko, Sergey A. ;
Hursting, Stephen D. .
NUTRIENTS, 2021, 13 (05)